European CLL Association (ECLLA)
Advancing care and research in Chronic Lymphocytic Leukemia
One Europe. Equal care.
📢 Featured News
📢 ECLLA Launches New European Insight Paper on Time Off Treatment in CLL
New ECLLA European Holistic Framework explores how people living with CLL can be supported before, during and after fixed-duration treatment The European CLL Association (ECLLA) is pleased to launch its new European Insight Paper, Time Off Treatment in CLL: The...
ABOUT ECLLA
The European CLL Association (ECLLA) works to improve equity, access and quality of care for people living with chronic lymphocytic leukemia (CLL) across Europe through advocacy, education, collaboration and policy engagement.
Mission
ECLLA unites clinicians, researchers, patient advocates, and industry partners to advance understanding of CLL.
Vision
Values
ECLLA’s actions and partnerships are guided by a shared ethical foundation, centered on respect and integrity in everything we do.
CORE FOCUS AREA
Policy & Access
ECLLA advocates for equitable access to innovative therapies and diagnostics across the EU. It participates in policy discussions to promote harmonised standards of care throughout Europe, ensuring that all patients benefit from advances in CLL treatment.
Partnership building & Collaboration
ECLLA brings together national CLL and blood cancer organisations, patient advocates, clinicians, researchers, and industry partners. By fostering networking and collaboration through forums and partnerships, ECLLA strengthens the CLL community across Europe and promotes the sharing of knowledge and best practice.
Patient Empowerment & Education
ECLLA is dedicated to developing accessible, multilingual educational materials that explain the biology of CLL, its diagnosis, treatment options, and long-term management strategies. This empowers patients and care partners to better understand the disease and its challenges, and to participate actively in treatment decisions.
Immunity & Infection Management
With a focus on the immune dysfunction that is central to CLL, ECLLA prioritises research and education on immunity and infection management. This includes establishing a dedicated working group and developing Europe-wide guidelines on vaccination and infection prevention for people living with CLL.
Research & Data Collaboration
ECLLA aims to establish a comprehensive European CLL Registry to collect anonymised data on treatment outcomes and immune-related complications. This collaborative effort will enhance research capabilities and promote standardised protocols across Europe.
Identified unmet needs
Across Europe, people living with CLL experience significant inequalities. ECLLA’s mission is to reduce these disparities by strengthening European collaboration, evidence-based advocacy, and shared learning to ensure equitable, high-quality CLL care regardless of geography.
ECLLA MEMBERSHIP
Full
Associate
Affiliated
Professional
Professional Members is intended for individual clinicians, researchers, and policy professionals.
We would like to thank the following ECLLA foundational funders for their support:
